Song B
Int J Mol Sci. 2025; 26(5).
PMID: 40076976
PMC: 11900391.
DOI: 10.3390/ijms26052357.
Laurent M, Geoffroy M, Pavani G, Guiraud S
Cells. 2024; 13(10.
PMID: 38786024
PMC: 11119143.
DOI: 10.3390/cells13100800.
Kim J, Yu J, Kim J, Park Y, Bae S, Kang K
BMB Rep. 2024; 57(2):79-85.
PMID: 38303561
PMC: 10910094.
Nandy K, Babu D, Rani S, Joshi G, Ijee S, George A
Sci Rep. 2023; 13(1):21953.
PMID: 38081875
PMC: 10713686.
DOI: 10.1038/s41598-023-42174-2.
Wang D, Chen Y, Zhu T, Wang J, Liu M, Tian S
Hortic Res. 2023; 10(9):uhad155.
PMID: 37719272
PMC: 10500149.
DOI: 10.1093/hr/uhad155.
Cell-specific and shared regulatory elements control a multigene locus active in mammary and salivary glands.
Lee H, Willi M, Liu C, Hennighausen L
Nat Commun. 2023; 14(1):4992.
PMID: 37591874
PMC: 10435465.
DOI: 10.1038/s41467-023-40712-0.
Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy.
Stampone E, Bencivenga D, Capellupo M, Roberti D, Tartaglione I, Perrotta S
Cell Mol Life Sci. 2023; 80(8):220.
PMID: 37477829
PMC: 10361942.
DOI: 10.1007/s00018-023-04852-2.
Base editors: development and applications in biomedicine.
Liang Y, Chen F, Wang K, Lai L
Front Med. 2023; 17(3):359-387.
PMID: 37434066
DOI: 10.1007/s11684-023-1013-y.
Optimization of Cas9 activity through the addition of cytosine extensions to single-guide RNAs.
Kawamata M, Suzuki H, Kimura R, Suzuki A
Nat Biomed Eng. 2023; 7(5):672-691.
PMID: 37037965
PMC: 10195680.
DOI: 10.1038/s41551-023-01011-7.
CRISPR/Cas9 therapeutics: progress and prospects.
Li T, Yang Y, Qi H, Cui W, Zhang L, Fu X
Signal Transduct Target Ther. 2023; 8(1):36.
PMID: 36646687
PMC: 9841506.
DOI: 10.1038/s41392-023-01309-7.
Systematic optimization of Cas12a base editors in wheat and maize using the ITER platform.
Gaillochet C, Pena Fernandez A, Goossens V, DHalluin K, Drozdzecki A, Shafie M
Genome Biol. 2023; 24(1):6.
PMID: 36639800
PMC: 9838060.
DOI: 10.1186/s13059-022-02836-2.
Correction of DMD in human iPSC-derived cardiomyocytes by base-editing-induced exon skipping.
Wang P, Li H, Zhu M, Han R, Guo S, Han R
Mol Ther Methods Clin Dev. 2023; 28:40-50.
PMID: 36588820
PMC: 9792405.
DOI: 10.1016/j.omtm.2022.11.010.
Genome Editing and Fatty Liver.
Hayat U, Siddiqui A, Farhan M, Haris A, Hameed N
Adv Exp Med Biol. 2022; 1396:191-206.
PMID: 36454468
DOI: 10.1007/978-981-19-5642-3_13.
CRISPR-Based Therapeutic Gene Editing for Duchenne Muscular Dystrophy: Advances, Challenges and Perspectives.
Chen G, Wei T, Yang H, Li G, Li H
Cells. 2022; 11(19).
PMID: 36230926
PMC: 9564082.
DOI: 10.3390/cells11192964.
Engineering a precise adenine base editor with minimal bystander editing.
Chen L, Zhang S, Xue N, Hong M, Zhang X, Zhang D
Nat Chem Biol. 2022; 19(1):101-110.
PMID: 36229683
DOI: 10.1038/s41589-022-01163-8.
hPSC gene editing for cardiac disease therapy.
Saleem A, Abbas M, Wang Y, Lan F
Pflugers Arch. 2022; 474(11):1123-1132.
PMID: 36163402
DOI: 10.1007/s00424-022-02751-2.
Application of CRISPR/Cas9 System in Establishing Large Animal Models.
Lin Y, Li J, Li C, Tu Z, Li S, Li X
Front Cell Dev Biol. 2022; 10:919155.
PMID: 35656550
PMC: 9152178.
DOI: 10.3389/fcell.2022.919155.
Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin.
Ravi N, Wienert B, Wyman S, Bell H, George A, Mahalingam G
Elife. 2022; 11.
PMID: 35147495
PMC: 8865852.
DOI: 10.7554/eLife.65421.
Human cell based directed evolution of adenine base editors with improved efficiency.
Fu J, Li Q, Liu X, Tu T, Lv X, Yin X
Nat Commun. 2021; 12(1):5897.
PMID: 34625552
PMC: 8501064.
DOI: 10.1038/s41467-021-26211-0.
Approaches to Enhance Precise CRISPR/Cas9-Mediated Genome Editing.
Denes C, Cole A, Aksoy Y, Li G, Neely G, Hesselson D
Int J Mol Sci. 2021; 22(16).
PMID: 34445274
PMC: 8395304.
DOI: 10.3390/ijms22168571.